Rufinamide Suspension
Product Images NDC 0054-0528

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 0054-0528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rufinamide Bottle Label

Rufinamide Bottle Label
This text provides information about an oral suspension medication called Rufinamide. The NDC code is 0054-0528-63 and it is contained in a 460mL bottle. The medication guide is enclosed and should be dispensed accordingly. The medication is meant for oral administration only and the container should be shaken before each use. It needs to be discarded within 90 days after opening and stored at 20° to 25°C (68° to 77°F), as per USP Controlled Room Temperature guidelines. It is recommended to see the accompanying prescribing information for dosage and use. The manufacturer and distributor of the medication is Hikma Pharmaceuticals USA Inc located in Berkeley Heights, NJ.*
FDA Label Image

Rufinamide Chem Structure

FDA Label Image

Rufinamide Fig A

Rufinamide Fig A
The text provided is not-available.*
FDA Label Image

Rufinamide Fig B

FDA Label Image

Rufinamide Fig C

FDA Label Image

Rufinamide Fig D

FDA Label Image

Rufinamide Fig E

FDA Label Image

Rufinamide Fig F

FDA Label Image

Rufinamide Fig G

FDA Label Image

Rufinamide Fig H

FDA Label Image

Rufinamide Fig I

FDA Label Image

Rufinamide Fig J

FDA Label Image

Rufinamide Fig K

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.